Rare urticaria

Rare urticaria (Orphanet code 79384) is a grouping term that encompasses uncommon forms of urticaria (hives) that do not fall under the more frequently encountered categories of chronic spontaneous or acute urticaria. These rare subtypes include conditions such as vibratory urticaria, aquagenic urticaria, cholinergic urticaria (rare severe forms), contact urticaria, and other physically induced or idiopathic rare variants. These disorders primarily affect the skin and immune system, characterized by the development of wheals (raised, itchy, often red or skin-colored swellings), angioedema (deeper tissue swelling), and pruritus (itching) triggered by specific and unusual stimuli such as water exposure, vibration, temperature changes, or pressure. The pathophysiology of rare urticarias generally involves mast cell degranulation and histamine release, though the precise mechanisms triggering this response vary by subtype and are not always fully understood. Some forms, such as vibratory urticaria, have been linked to specific genetic mutations (e.g., ADGRE2 gene), while others appear to be acquired or multifactorial in origin. The condition can significantly impact quality of life, as patients may need to avoid specific environmental triggers that are difficult to control. Treatment for rare urticarias follows a stepwise approach similar to other forms of chronic urticaria. First-line therapy typically involves second-generation H1-antihistamines, often at higher-than-standard doses. For refractory cases, omalizumab (an anti-IgE monoclonal antibody) has shown efficacy in some subtypes. Additional options may include H2-antihistamines, leukotriene receptor antagonists, and in severe cases, short courses of systemic corticosteroids. Trigger avoidance remains a cornerstone of management. Given the rarity and heterogeneity of these conditions, treatment is often individualized, and patients may benefit from referral to specialized allergy or dermatology centers.

Common questions about Rare urticaria